Table 2.

Inflammation and disease activity markers correlate with Bacteriuria

Bacteriuria	Never	Intermittent	Persistent	p-value
Anti-Curli/eDNA Abs	0.44 (±0.14)	0.48 (±0.16)	0.71* (±0.25)	0.001
Hgb	11.19 (±1.47)	11.06 (±1.8)	10.76* (±1.86)	0.01
Lymph (Absol. count)	1527 (±1269)	694* (±878)	575* (±697)	0.0001
PLTs (Absol. count)	230.7 (±103.3)	253.04* (±109.6)	257.5* (±86.5)	0.004
PMNs (%)	57 (±12.70)	58.9 (±15.3)	67.88*+ (±11.1)	0.0004
ESR	33.72 (±24)	51.36* (±36.7)	66.3* (±35.9)	0.0001
C3	113.57 (±15.4)	113.75 (±30.80)	96.38*+ (±27.12)	0.0001
Globulin	3.38 (±0.51)	3.65* (±0.6)	3.92*+ (±0.75)	0.0001
anti-dsDNA	7.65 (±8.17)	35.26 (±32.52)	87.9*+ (±101.81)	0.0001
Flares (%)	50	66	90	0.03

Averages and ± SD of laboratory results from 27 SLE patients. O.D. of anti-curli/eDNA Abs in plasma; Peripheral blood Absolute counts of Lymphocytes (Lymph) and platelets (PLTs); % of polymorphonucleated cells (PMNs); Erythrocyte Sedimentation Rate (ESR); Complement 3 (C3) mg/dl; Globulin; % of SLE patients who had Flares. Results from one-way ANOVA are reported as in the column of the right. Results from the post-hoc t-tests of the comparisons between Intermittent and Persistent vs Never are signaled with * close to the numbers, while the comparisons between Intermittent vs Persistent with ⁺. Values ≤ 0.05 were considered significant. n.s.= not significant.

^*p < 0.05

^**p < 0.01

^***p < 0.001